US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 37.820
  • -1.070-2.75%
Close Mar 28 16:00 ET
  • 37.820
  • 0.0000.00%
Post 20:01 ET
3.50BMarket Cap-6.01P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.77%-414.19M
5.25%-79.5M
43.16%-67M
33.74%-76.96M
-21.59%-190.73M
-24.80%-474.81M
7.13%-83.9M
-23.63%-117.87M
-50.36%-116.16M
-33.48%-156.87M
Net income from continuing operations
6.17%-569.18M
-8.28%-133.39M
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
Depreciation and amortization
36.67%35.54M
10.48%9.08M
21.78%8.76M
65.30%8.86M
68.93%8.85M
42.73%26.01M
65.79%8.22M
53.20%7.19M
19.64%5.36M
28.08%5.24M
Other non cash items
-3,766.70%-40.99M
-66.16%-16.85M
-492.03%-10.84M
-40,640.74%-11M
-120.96%-2.29M
-101.10%-1.06M
-214.99%-10.14M
-102.17%-1.83M
-102.76%-27K
514.32%10.94M
Change In working capital
192.17%13.92M
71.01%22.75M
1,001.00%30.83M
128.50%16.36M
-46.02%-56.02M
-125.07%-15.1M
-39.11%13.3M
-87.37%2.8M
-74.35%7.16M
-228.21%-38.36M
-Change in receivables
-47.50%-33.6M
-2,139.53%-20.64M
257.83%9.79M
114.31%2.16M
-893.14%-24.91M
-88.75%-22.78M
111.13%1.01M
-204.64%-6.2M
-68.75%-15.08M
-7,700.00%-2.51M
-Change in inventory
-61.72%-11.21M
-25.56%-2.46M
27.89%-2.5M
-149.06%-4.13M
-1,516.00%-2.12M
28.56%-6.93M
53.48%-1.96M
-338.31%-3.47M
48.70%-1.66M
110.17%150K
-Change in prepaid assets
-23.45%11.73M
57.27%-538K
----
----
1,362.62%6.55M
303.50%15.33M
-138.86%-1.26M
----
----
-105.69%-519K
-Change in payables and accrued expense
5,115.54%46.99M
170.85%46.39M
44.61%10.82M
115.00%25.33M
-0.15%-35.54M
-98.87%901K
-37.56%17.13M
-32.94%7.48M
-79.48%11.78M
-119.54%-35.49M
-Change in other working capital
----
----
----
----
----
1.22%-1.62M
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
12.77%-414.19M
5.25%-79.5M
43.16%-67M
33.74%-76.96M
-21.59%-190.73M
-24.80%-474.81M
7.13%-83.9M
-23.63%-117.87M
-50.36%-116.16M
-33.48%-156.87M
Investing cash flow
Cash flow from continuing investing activities
-110.58%-17.77M
196.00%102.74M
-528.50%-275.5M
-39.08%60.56M
-15.16%94.44M
157.60%168M
37.64%-107.02M
139.72%64.3M
25.58%99.42M
397.91%111.3M
Net PPE purchase and sale
83.08%-7.49M
59.13%-654K
56.24%-1.62M
85.59%-2.01M
87.17%-3.21M
61.88%-44.27M
94.07%-1.6M
85.81%-3.7M
54.93%-13.94M
22.22%-25.03M
Net intangibles purchase and sale
-400.00%-12.5M
--0
--0
0.00%-2.5M
---10M
91.67%-2.5M
--0
--0
---2.5M
--0
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-97.88%4.66M
198.45%103.52M
-500.01%-273.68M
-43.99%65.11M
-21.80%109.71M
415.55%219.82M
27.18%-105.15M
213.57%68.42M
5.42%116.25M
467.93%140.29M
Net other investing changes
51.74%-2.44M
53.14%-127K
52.57%-203K
89.70%-41K
47.73%-2.07M
-498.10%-5.05M
55.13%-271K
-141.81%-428K
-117.49%-398K
-3,392.50%-3.95M
Cash from discontinued investing activities
Investing cash flow
-110.58%-17.77M
196.00%102.74M
-528.50%-275.5M
-39.08%60.56M
-15.16%94.44M
157.60%168M
37.64%-107.02M
139.72%64.3M
25.58%99.42M
397.91%111.3M
Financing cash flow
Cash flow from continuing financing activities
2.86%399.24M
-99.04%3.19M
-55.72%11.17M
1,065.78%384.94M
91.97%-58K
-22.56%388.14M
17,466.95%330.61M
-94.87%25.23M
465.70%33.02M
-144.79%-722K
Net common stock issuance
0.32%380.98M
--0
-99.53%117K
----
----
--379.76M
--326.46M
--24.79M
----
----
Proceeds from stock option exercised by employees
33.78%11.26M
-23.30%3.19M
817.87%4.06M
-10.86%4.07M
92.27%-58K
-22.18%8.42M
107.60%4.15M
-58.85%442K
-23.63%4.57M
-142.74%-750K
Net other financing activities
25,100.00%7M
--0
----
----
----
-100.01%-28K
--0
--0
61.64%-56K
119.58%28K
Cash from discontinued financing activities
Financing cash flow
2.86%399.24M
-99.04%3.19M
-55.72%11.17M
1,065.78%384.94M
91.97%-58K
-22.56%388.14M
17,466.95%330.61M
-94.87%25.23M
465.70%33.02M
-144.79%-722K
Net cash flow
Beginning cash position
59.45%219.4M
103.82%160.21M
355.35%490.26M
33.70%122.37M
59.45%219.4M
-55.55%137.6M
-80.17%78.61M
-33.83%107.67M
-41.41%91.53M
-55.55%137.6M
Current changes in cash
-140.22%-32.72M
-81.09%26.42M
-1,068.89%-331.32M
2,164.18%368.54M
-108.17%-96.35M
147.59%81.34M
153.71%139.69M
-112.08%-28.35M
110.08%16.28M
69.80%-46.29M
Effect of exchange rate changes
-646.54%-2.53M
-324.21%-2.47M
278.07%1.28M
-376.47%-648K
-421.80%-679K
142.98%462K
-18.42%1.1M
33.77%-716K
89.01%-136K
295.37%211K
End cash Position
-16.06%184.16M
-16.06%184.16M
103.82%160.21M
355.35%490.26M
33.70%122.37M
59.45%219.4M
59.45%219.4M
-80.17%78.61M
-33.83%107.67M
-41.41%91.53M
Free cash flow
16.76%-434.18M
6.25%-80.16M
43.56%-68.61M
38.56%-81.47M
-12.11%-203.94M
0.95%-521.57M
27.11%-85.5M
-0.15%-121.57M
-22.57%-132.6M
-1.22%-181.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.77%-414.19M5.25%-79.5M43.16%-67M33.74%-76.96M-21.59%-190.73M-24.80%-474.81M7.13%-83.9M-23.63%-117.87M-50.36%-116.16M-33.48%-156.87M
Net income from continuing operations 6.17%-569.18M-8.28%-133.39M16.37%-133.52M17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M
Depreciation and amortization 36.67%35.54M10.48%9.08M21.78%8.76M65.30%8.86M68.93%8.85M42.73%26.01M65.79%8.22M53.20%7.19M19.64%5.36M28.08%5.24M
Other non cash items -3,766.70%-40.99M-66.16%-16.85M-492.03%-10.84M-40,640.74%-11M-120.96%-2.29M-101.10%-1.06M-214.99%-10.14M-102.17%-1.83M-102.76%-27K514.32%10.94M
Change In working capital 192.17%13.92M71.01%22.75M1,001.00%30.83M128.50%16.36M-46.02%-56.02M-125.07%-15.1M-39.11%13.3M-87.37%2.8M-74.35%7.16M-228.21%-38.36M
-Change in receivables -47.50%-33.6M-2,139.53%-20.64M257.83%9.79M114.31%2.16M-893.14%-24.91M-88.75%-22.78M111.13%1.01M-204.64%-6.2M-68.75%-15.08M-7,700.00%-2.51M
-Change in inventory -61.72%-11.21M-25.56%-2.46M27.89%-2.5M-149.06%-4.13M-1,516.00%-2.12M28.56%-6.93M53.48%-1.96M-338.31%-3.47M48.70%-1.66M110.17%150K
-Change in prepaid assets -23.45%11.73M57.27%-538K--------1,362.62%6.55M303.50%15.33M-138.86%-1.26M---------105.69%-519K
-Change in payables and accrued expense 5,115.54%46.99M170.85%46.39M44.61%10.82M115.00%25.33M-0.15%-35.54M-98.87%901K-37.56%17.13M-32.94%7.48M-79.48%11.78M-119.54%-35.49M
-Change in other working capital --------------------1.22%-1.62M----------------
Cash from discontinued investing activities
Operating cash flow 12.77%-414.19M5.25%-79.5M43.16%-67M33.74%-76.96M-21.59%-190.73M-24.80%-474.81M7.13%-83.9M-23.63%-117.87M-50.36%-116.16M-33.48%-156.87M
Investing cash flow
Cash flow from continuing investing activities -110.58%-17.77M196.00%102.74M-528.50%-275.5M-39.08%60.56M-15.16%94.44M157.60%168M37.64%-107.02M139.72%64.3M25.58%99.42M397.91%111.3M
Net PPE purchase and sale 83.08%-7.49M59.13%-654K56.24%-1.62M85.59%-2.01M87.17%-3.21M61.88%-44.27M94.07%-1.6M85.81%-3.7M54.93%-13.94M22.22%-25.03M
Net intangibles purchase and sale -400.00%-12.5M--0--00.00%-2.5M---10M91.67%-2.5M--0--0---2.5M--0
Net business purchase and sale --0------------------0----------------
Net investment purchase and sale -97.88%4.66M198.45%103.52M-500.01%-273.68M-43.99%65.11M-21.80%109.71M415.55%219.82M27.18%-105.15M213.57%68.42M5.42%116.25M467.93%140.29M
Net other investing changes 51.74%-2.44M53.14%-127K52.57%-203K89.70%-41K47.73%-2.07M-498.10%-5.05M55.13%-271K-141.81%-428K-117.49%-398K-3,392.50%-3.95M
Cash from discontinued investing activities
Investing cash flow -110.58%-17.77M196.00%102.74M-528.50%-275.5M-39.08%60.56M-15.16%94.44M157.60%168M37.64%-107.02M139.72%64.3M25.58%99.42M397.91%111.3M
Financing cash flow
Cash flow from continuing financing activities 2.86%399.24M-99.04%3.19M-55.72%11.17M1,065.78%384.94M91.97%-58K-22.56%388.14M17,466.95%330.61M-94.87%25.23M465.70%33.02M-144.79%-722K
Net common stock issuance 0.32%380.98M--0-99.53%117K----------379.76M--326.46M--24.79M--------
Proceeds from stock option exercised by employees 33.78%11.26M-23.30%3.19M817.87%4.06M-10.86%4.07M92.27%-58K-22.18%8.42M107.60%4.15M-58.85%442K-23.63%4.57M-142.74%-750K
Net other financing activities 25,100.00%7M--0-------------100.01%-28K--0--061.64%-56K119.58%28K
Cash from discontinued financing activities
Financing cash flow 2.86%399.24M-99.04%3.19M-55.72%11.17M1,065.78%384.94M91.97%-58K-22.56%388.14M17,466.95%330.61M-94.87%25.23M465.70%33.02M-144.79%-722K
Net cash flow
Beginning cash position 59.45%219.4M103.82%160.21M355.35%490.26M33.70%122.37M59.45%219.4M-55.55%137.6M-80.17%78.61M-33.83%107.67M-41.41%91.53M-55.55%137.6M
Current changes in cash -140.22%-32.72M-81.09%26.42M-1,068.89%-331.32M2,164.18%368.54M-108.17%-96.35M147.59%81.34M153.71%139.69M-112.08%-28.35M110.08%16.28M69.80%-46.29M
Effect of exchange rate changes -646.54%-2.53M-324.21%-2.47M278.07%1.28M-376.47%-648K-421.80%-679K142.98%462K-18.42%1.1M33.77%-716K89.01%-136K295.37%211K
End cash Position -16.06%184.16M-16.06%184.16M103.82%160.21M355.35%490.26M33.70%122.37M59.45%219.4M59.45%219.4M-80.17%78.61M-33.83%107.67M-41.41%91.53M
Free cash flow 16.76%-434.18M6.25%-80.16M43.56%-68.61M38.56%-81.47M-12.11%-203.94M0.95%-521.57M27.11%-85.5M-0.15%-121.57M-22.57%-132.6M-1.22%-181.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
NVIDIA
NVDA
-1.58%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%

Unlock the Full List